
OncoEthix closes CHF18m series B financing
OncoEthix, the Swiss-based specialist in oncology drug development, has closed a series B financing raising CHF18m (USD19m). SV Life Sciences (SVLS) led the financing, joined by new investor Edmond de Rothschild Investment Partners. Existing investors including Index Ventures and Endeavour Vision also participated in the round. The proceeds will be



